Biotechnology
Bulgarian companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Novavax, Inc. ranks as the top gainer, and Moderna, Inc. sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 0QFModerna, Inc. | 91.88 B EUR | 194.700 EUR | −1.54% | 0 | — | — | −6.99 EUR | −9.55% | 0.00% | Health technology | Neutral |
 NVV1Novavax, Inc. | 1.56 B EUR | 9.27 EUR | +2.54% | 0 | — | — | −1.33 EUR | −169.59% | 0.00% | Health technology | Buy |
 AYJValneva SE | 481.73 M EUR | 2.479 EUR | −2.32% | 0 | — | — | −0.90 EUR | −117.39% | 0.00% | Health technology | Strong buy |